nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—Pain in extremity—Metformin—polycystic ovary syndrome	0.00882	0.0553	CcSEcCtD
Cinacalcet—Dehydration—Metformin—polycystic ovary syndrome	0.0082	0.0514	CcSEcCtD
Cinacalcet—Cramp muscle—Metformin—polycystic ovary syndrome	0.00794	0.0498	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00708	0.0444	CcSEcCtD
Cinacalcet—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00601	0.0377	CcSEcCtD
Cinacalcet—Propranolol—ADRB3—polycystic ovary syndrome	0.00573	0.586	CrCbGaD
Cinacalcet—Immune system disorder—Metformin—polycystic ovary syndrome	0.00551	0.0346	CcSEcCtD
Cinacalcet—Malnutrition—Metformin—polycystic ovary syndrome	0.00531	0.0333	CcSEcCtD
Cinacalcet—Muscle spasms—Metformin—polycystic ovary syndrome	0.00511	0.032	CcSEcCtD
Cinacalcet—Hypertension—Metformin—polycystic ovary syndrome	0.00459	0.0288	CcSEcCtD
Cinacalcet—Chest pain—Metformin—polycystic ovary syndrome	0.00452	0.0284	CcSEcCtD
Cinacalcet—Myalgia—Metformin—polycystic ovary syndrome	0.00452	0.0284	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00449	0.0282	CcSEcCtD
Cinacalcet—Infection—Metformin—polycystic ovary syndrome	0.00431	0.027	CcSEcCtD
Cinacalcet—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00425	0.0267	CcSEcCtD
Cinacalcet—Skin disorder—Metformin—polycystic ovary syndrome	0.00421	0.0264	CcSEcCtD
Cinacalcet—Anorexia—Metformin—polycystic ovary syndrome	0.00413	0.0259	CcSEcCtD
Cinacalcet—Hypotension—Metformin—polycystic ovary syndrome	0.00405	0.0254	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00395	0.0248	CcSEcCtD
Cinacalcet—Paraesthesia—Metformin—polycystic ovary syndrome	0.00389	0.0244	CcSEcCtD
Cinacalcet—Dyspnoea—Metformin—polycystic ovary syndrome	0.00386	0.0242	CcSEcCtD
Cinacalcet—Dyspepsia—Metformin—polycystic ovary syndrome	0.00382	0.0239	CcSEcCtD
Cinacalcet—Decreased appetite—Metformin—polycystic ovary syndrome	0.00377	0.0236	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00374	0.0235	CcSEcCtD
Cinacalcet—Fatigue—Metformin—polycystic ovary syndrome	0.00374	0.0234	CcSEcCtD
Cinacalcet—Constipation—Metformin—polycystic ovary syndrome	0.00371	0.0232	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00354	0.0222	CcSEcCtD
Cinacalcet—Urticaria—Metformin—polycystic ovary syndrome	0.00344	0.0216	CcSEcCtD
Cinacalcet—Abdominal pain—Metformin—polycystic ovary syndrome	0.00343	0.0215	CcSEcCtD
Cinacalcet—Asthenia—Metformin—polycystic ovary syndrome	0.00311	0.0195	CcSEcCtD
Cinacalcet—Pruritus—Metformin—polycystic ovary syndrome	0.00307	0.0192	CcSEcCtD
Cinacalcet—Diarrhoea—Metformin—polycystic ovary syndrome	0.00297	0.0186	CcSEcCtD
Cinacalcet—Dizziness—Metformin—polycystic ovary syndrome	0.00287	0.018	CcSEcCtD
Cinacalcet—Vomiting—Metformin—polycystic ovary syndrome	0.00276	0.0173	CcSEcCtD
Cinacalcet—Rash—Metformin—polycystic ovary syndrome	0.00273	0.0171	CcSEcCtD
Cinacalcet—Dermatitis—Metformin—polycystic ovary syndrome	0.00273	0.0171	CcSEcCtD
Cinacalcet—Headache—Metformin—polycystic ovary syndrome	0.00272	0.017	CcSEcCtD
Cinacalcet—Nausea—Metformin—polycystic ovary syndrome	0.00257	0.0161	CcSEcCtD
Cinacalcet—Propranolol—ADRB2—polycystic ovary syndrome	0.00218	0.223	CrCbGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00193	0.00233	CbGpPWpGaD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00193	0.00233	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00193	0.00232	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LHB—polycystic ovary syndrome	0.0019	0.00229	CbGpPWpGaD
Cinacalcet—Propranolol—CYP1A1—polycystic ovary syndrome	0.00187	0.191	CrCbGaD
Cinacalcet—CASR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00186	0.00224	CbGpPWpGaD
Cinacalcet—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00186	0.00223	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00182	0.00219	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.0018	0.00217	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0018	0.00217	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0018	0.00216	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SCT—polycystic ovary syndrome	0.00178	0.00215	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00176	0.00212	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00174	0.0021	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00171	0.00205	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.0017	0.00205	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00169	0.00204	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00167	0.00201	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00167	0.00201	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00166	0.002	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00166	0.002	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00165	0.00199	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00163	0.00197	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00162	0.00195	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00158	0.0019	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00156	0.00188	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00155	0.00186	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00153	0.00184	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00151	0.00182	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00148	0.00178	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—INSR—polycystic ovary syndrome	0.00146	0.00176	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00141	0.00169	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00139	0.00167	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00139	0.00167	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.00137	0.00165	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00137	0.00165	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00137	0.00164	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PGR—polycystic ovary syndrome	0.00135	0.00163	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00134	0.00161	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00134	0.00161	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00134	0.00161	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00134	0.00161	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00132	0.00159	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00132	0.00159	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00131	0.00157	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00129	0.00155	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00129	0.00155	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00128	0.00154	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00128	0.00154	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00128	0.00154	CbGpPWpGaD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00126	0.00152	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00126	0.00151	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00126	0.00151	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00125	0.00151	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00121	0.00146	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ATF1—polycystic ovary syndrome	0.0012	0.00144	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00117	0.00141	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00116	0.0014	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00114	0.00137	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00112	0.00135	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00111	0.00133	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—POMC—polycystic ovary syndrome	0.0011	0.00132	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PRL—polycystic ovary syndrome	0.0011	0.00132	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00109	0.00131	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00108	0.0013	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00107	0.00128	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00106	0.00128	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00106	0.00127	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00105	0.00126	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00104	0.00125	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00103	0.00125	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00103	0.00124	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00103	0.00124	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00103	0.00124	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00102	0.00123	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000993	0.0012	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000965	0.00116	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000951	0.00114	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000949	0.00114	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000926	0.00112	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00092	0.00111	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000914	0.0011	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000903	0.00109	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000886	0.00107	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000876	0.00105	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000874	0.00105	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000863	0.00104	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000861	0.00104	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000849	0.00102	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000841	0.00101	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000839	0.00101	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000834	0.001	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000823	0.000991	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000806	0.00097	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000785	0.000945	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000774	0.000932	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000773	0.000931	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000771	0.000928	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LEP—polycystic ovary syndrome	0.000757	0.000911	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000733	0.000882	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000731	0.00088	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00073	0.000878	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00072	0.000866	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000684	0.000823	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000681	0.00082	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000676	0.000814	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000675	0.000812	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000674	0.000812	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000672	0.000809	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000665	0.0008	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000665	0.0008	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000653	0.000786	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—POMC—polycystic ovary syndrome	0.00065	0.000782	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—INS—polycystic ovary syndrome	0.000646	0.000778	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000626	0.000754	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000625	0.000753	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000625	0.000752	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000622	0.000749	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000606	0.000729	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000597	0.000719	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000594	0.000715	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000577	0.000695	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000569	0.000685	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000564	0.000679	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000563	0.000678	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000557	0.00067	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000555	0.000668	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000549	0.000661	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000542	0.000652	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000528	0.000635	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000504	0.000607	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000504	0.000606	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000483	0.000582	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000478	0.000575	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000465	0.00056	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000459	0.000552	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000446	0.000536	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000442	0.000532	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000442	0.000532	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000439	0.000529	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000428	0.000515	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000411	0.000495	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.00041	0.000493	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000409	0.000493	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000408	0.000492	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00039	0.00047	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000382	0.000459	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000374	0.000451	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000374	0.000451	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00037	0.000445	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000359	0.000432	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000354	0.000426	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000349	0.000421	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000349	0.000421	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000348	0.000419	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000347	0.000418	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00034	0.000409	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000318	0.000382	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000316	0.00038	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000301	0.000363	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000296	0.000356	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000296	0.000356	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000293	0.000352	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000289	0.000348	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000289	0.000348	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000285	0.000343	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—polycystic ovary syndrome	0.000282	0.00034	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00028	0.000337	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000278	0.000334	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000269	0.000323	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000268	0.000322	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000265	0.000319	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000248	0.000299	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000236	0.000284	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000235	0.000283	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000228	0.000275	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000228	0.000275	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000225	0.000271	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000224	0.00027	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000222	0.000267	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000205	0.000247	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000201	0.000242	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.0002	0.000241	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000194	0.000234	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000191	0.00023	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000191	0.00023	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000189	0.000227	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000181	0.000218	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000179	0.000215	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000179	0.000215	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000174	0.000209	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000173	0.000208	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000173	0.000208	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.00017	0.000205	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000167	0.000201	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000165	0.000198	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.00016	0.000193	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000158	0.000191	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000154	0.000186	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000152	0.000182	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.00015	0.00018	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000147	0.000177	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000147	0.000177	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000147	0.000177	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000141	0.00017	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000136	0.000164	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000135	0.000163	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000134	0.000162	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000134	0.000162	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000133	0.00016	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000131	0.000158	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000127	0.000153	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000127	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000127	0.000153	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000125	0.00015	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000124	0.000149	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000117	0.000141	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000117	0.00014	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000113	0.000136	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000109	0.000131	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TH—polycystic ovary syndrome	0.000108	0.00013	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000105	0.000126	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000105	0.000126	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	0.000104	0.000125	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000104	0.000125	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.91e-05	0.000119	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.87e-05	0.000119	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.78e-05	0.000118	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.63e-05	0.000116	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	9.39e-05	0.000113	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	8.81e-05	0.000106	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.76e-05	0.000105	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	8.4e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.33e-05	0.0001	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.1e-05	9.76e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.96e-05	9.58e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.62e-05	9.17e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.42e-05	8.93e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.1e-05	8.55e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	7e-05	8.43e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.97e-05	8.38e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.8e-05	8.19e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.48e-05	7.8e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.14e-05	7.39e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	6.02e-05	7.24e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.93e-05	7.14e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.9e-05	7.1e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.73e-05	6.89e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.64e-05	5.59e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.58e-05	5.51e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.55e-05	5.48e-05	CbGpPWpGaD
